Company Filing History:
1 out of 3,923 
1 out of 1,384 
1 out of 832,843 Years Active: 2002-2004
Title: Martin Krüger: Innovator in Pharmaceutical Chemistry
Introduction
Martin Krüger is a distinguished inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 3 patents to his name, Krüger's work focuses on innovative solutions for treating diseases associated with angiogenesis.
Latest Patents
Among his latest patents is the invention titled "Anthranylalkyl and cycloalkyl amides and use thereof as VEGF receptor inhibitors." This invention relates to substituted anthranylalkyl and cycloalkyl amides of general formula (I) and their application as medicaments for treating diseases caused by persistent angiogenesis. Another notable patent is for "Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents." This patent describes the production of these derivatives, as well as intermediate products for their production, and their use as pharmaceutical agents for treating various diseases.
Career Highlights
Throughout his career, Martin Krüger has worked with prominent companies in the pharmaceutical industry, including Novartis AG. His expertise in the field has allowed him to develop innovative solutions that address critical health challenges.
Collaborations
Krüger has collaborated with notable professionals in his field, including Martin Haberey and Andreas Huth. These collaborations have further enhanced his research and development efforts.
Conclusion
Martin Krüger's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.